Image

Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity

Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity

Recruiting
30-50 years
Female
Phase N/A

Powered by AI

Overview

The study aimed to explore the link between urinary incontinence (UI) severity in patients with multiple sclerosis (PwMS), electromyography (EMG) findings, and other relevant factors.

Description

The study will consist of a cross-sectional observational analysis involving a cohort of 47 PwMS. The assessment will be employed various instruments, including the Expanded Disability Status Scale (EDSS), Neurogenic Bladder Symptom Score (NBSS), International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF), Incontinence Impact Questionnaire (IIQ-7), International Physical Activity Questionnaire (IPAQ), Fatigue Severity Scale (FSS), EMG.

Eligibility

Inclusion Criteria:

  • having an MS diagnosis according to the 2017 revised McDonald criteria,
  • experiencing symptoms of UI as defined by the International Continence Society (ICS),
  • having an EDSS score below 6.5,
  • PwMS with no communication issues.

Exclusion Criteria:

  • PwMS who did not give consent to participate,
  • those with medication changes in the past 6 months,
  • pregnant PwMS,
  • recent vaginal or caesarean deliveries within 6 months,
  • pelvic organ prolapse,
  • urinary tract infection,
  • recent attack history in the past month.

Study details
    Multiple Sclerosis

NCT07236684

Artvin Coruh University

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.